Tests exercise training in people with lupus
Tests high-intensity interval and resistance training in adults with systemic lupus erythematosus.
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Stockholm, SwedenSee the site
- Trial code
- Registry title
- Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 1 Nov 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- HIIT combined with resistance training
- Record updated
- 12 December 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with systemic lupus erythematosus (SLE) who have low to moderate disease activity and little or no organ damage. It tests high-intensity interval training combined with resistance training.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Low to moderate disease activity (for example a SLEDAI-2K score of 5 or less) and low, minimal or no organ damage (for example a SLICC/ACR DI score of 3 or less).
- Earlier treatment
- Medicine treatment must be stable. People who do regular aerobic fitness and muscle strength training at fixed times more than 1 time a week cannot join.
Main reasons for not taking part
- Signs of cerebro-vascular disease, pulmonary embolus, pulmonary hypertension, pulmonary fibrosis or cardiovascular disease within one year before entry
- Angina pectoris, myocardial infarction, dyspnea at rest, uncontrolled blood pressure or uncontrolled diabetes within one year before entry
- Cannot do a maximal exercise cycle test because of the disease or health risks
- Other conditions that strongly reduce the ability to exercise
- Pregnancy
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- ≥18 years old
- Fulfilment of the 1982 American College of Rheumatology (ACR) criteria; or 2012 Systemic Lupus International Collaborating Clinics (SLICC/ACR-Damage Index (DI)) classification criteria; or EULAR/ACR criteria; or patients that have received the diagnosis SLE on clinical grounds
- Low to moderate disease activity, for example defined as a score of ≤5 in the clinical version of the SLE Disease Activity Index 2000 (SLEDAI-2K), i.e., excluding the serological descriptors (anti-dsDNA positivity and low complement levels)
- Low/minimal or no organ damage, for example defined as a score of ≤3 in the SLICC/ACR DI
- Stable pharmacological treatment
- The ability to perform a maximal ergometercycle exercise test
- Be able to read and understand Swedish
Who cannot take part
- Symptoms or signs of cerebro-vascular disease, pulmonary embolus, pulmonary hypertension, pulmonary fibrosis, cardiovascular disease, angina pectoris, myocardial infarction, dyspnea at rest, uncontrolled blood pressure and uncontrolled diabetes within one year prior to study entry. Chronic kidney disease with
- Patients who fulfil the absolute contraindications for maximal exercise testing according to American Heart Association
- Patients who cannot perform a maximal ergometercycle exercise test due to the disease
- Diseases or other conditions that strongly reduce the ability to exercise or that exercise is not recommended
- Patients who perform regular aerobic fitness training and muscle strength exercise sessions at fixed times, >1 time/week
- Pregnancy
Where in Sweden
- Carina BoströmStockholm, SwedenContact: Carina M Boström, DrTaking people
About the trial
What the trial wants to find out
The aim of this study is to evaluate the safety and effects of high-intensity interval training (HIIT) combined with resistance training in patients with systemic lupus erythematosus
The 2 groups in the trial
- High-intensity interval training (HIIT) combined with resistance trainingTreatment being tested
Patients with SLE will undergo supervised HIIT on an ergometercycle 4 x 4 minutes interval (85-90% of maximal heart rate in 4 minutes and lower intensity for another 4 minutes etc). The HIIT is combined with resistance exercises for upper and lower extremity. In total the supervised training takes around 50 minutes per occasion and will be performed 2 times/week, for 3 months. In addition, the patients will exercise, according to the program, by themselves once a week. Between months 3 and 6 the patients exercise by themselves, 3 times/week, with video-call/telephone support from a physiotherapist once a week.
Treatment: HIIT combined with resistance training
- Control groupNo study treatment, for comparison
Both the control group and the HIIT combined with resistance training group receive standard care.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of High-intensity Interval Training Combined With Resistance Training in Patients With Systemic Lupus Erythematosus
- Plain-language title
- Tests exercise training in people with lupusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 December 2023